Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

B. Riley shares plummet after investment losses, ratings downgrade on Franchise Group

Published 11/14/2023, 07:56 PM
Updated 11/14/2023, 08:10 PM
© Reuters. A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 27, 2023.  REUTERS/Brendan McDermid

(This Nov. 13 story has been corrected by removing a reference to mark down in value of investment in Franchise Group (NASDAQ:FRG) in paragraph 2)

By Chibuike Oguh

NEW YORK (Reuters) - Shares of financial services firm B. Riley plummeted nearly 35% on Monday, extending losses for the fourth consecutive session, after it disclosed unrealized investment losses and S&P Global Ratings downgraded a key asset.

The boutique Los Angeles-based investment bank said last week it was forced to mark down the value of its equities portfolio resulting in a net loss of $75.8 million in the third quarter, compared with a profit of $45.8 million a year earlier.

S&P Global Ratings also downgraded the credit rating of Vitamin Shoppe owner Franchise Group Inc on Friday, following a $2.6 billion take-private deal involving a consortium of investors including B. Riley.

The ratings agency slashed Franchise Group's debt rating, dropping it further down in junk status to 'B-' from 'B' with a negative outlook, after the company reported a decline in revenue and a net loss in the third quarter.

B. Riley's stock plunged to as low as $16.65 on Monday, shedding nearly 50% of its value since the announcement. Its shares have pared some of those losses and were last down nearly 14% to $21.90.

"We do not believe that the recent movement in our share price is warranted based on the fundamental strength and performance of our diversified platform," a B. Riley spokesperson said in a statement.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

S&P also said it was monitoring legal developments relating to Franchise Group's Chief Executive Brian Kahn, who led the August take-private deal.

Bloomberg reported this month that Kahn is one of two co-conspirators named by co-founder of hedge fund Prophecy Asset Management John Hughes, who this month pleaded guilty to securities fraud. It's unclear if Kahn is also facing charges, Bloomberg reported.

"At no time during my former business relationship with Prophecy did I know that Prophecy or its principals were allegedly defrauding their investors, nor did I conspire in any fraud," Kahn said in a statement to Reuters.

Bryant Riley, B.Riley's eponymous CEO, said during an analyst earnings call last week that it had invested in Franchise Group based on the fundamentals of the business and that Kahn had no "direct experience with what has been alleged."

B. Riley has also been targeted by a short seller. In February, Wolfpack Research accused the company of not cutting losses on "failing" investments and continuing to extend capital to distressed clients.

"Although B Riley attempted to address short seller concerns on their recent earnings call, the information they provided was limited," said Rick Meckler, partner at Cherry Lane Investments.

"It remains to be seen whether this is a real problem for RILY, but investors and clients sometimes don't wait around for greater clarity," Meckler added.

Latest comments

Typical crooks in IB.....
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.